The DOI matches its Crossref record; 313 of the 313 references it cites were found in a registry or an index.
Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential
Open accessAbstract
Oxidative stress has become widely viewed as an underlying condition in a number of diseases, such as ischemia–reperfusion disorders, central nervous system disorders, cardiovascular conditions, cancer, and diabetes. Thus, natural and synthetic antioxidants have been actively sought. Superoxide dismutase is a first line of defense against oxidative stress under physiological and pathological conditions. Therefore, the development of therapeutics aimed at mimicking superoxide dismutase was a natural maneuver. Metalloporphyrins, as well as Mn cyclic polyamines, Mn salen derivatives and nitroxides were all originally developed as SOD mimics. The same thermodynamic and electrostatic properties that make them potent SOD mimics may allow them to reduce other reactive species such as peroxynitrite, peroxynitrite-derived CO 3 ·− , peroxyl radical, and less efficiently H 2 O 2 . By doing so SOD mimics can decrease both primary and secondary oxidative events, the latter arising from the inhibition of cellular transcriptional activity. To better judge the therapeutic potential and the advantage of one over the other type of compound, comparative studies of different classes of drugs in the same cellular and/or animal models are needed. We here provide a comprehensive overview of the chemical properties and some in vivo effects observed with various classes of compounds with a special emphasis on porphyrin-based compounds. Antioxid. Redox Signal. 13, 877–918.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Self-citationA Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Reconciling the chemistry and biology of reactive oxygen species
Winterbourn, C. C. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.85 · Cited by 2,504
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles
Korsvik, C., Patil, S., Seal, S., & Self, W. T. (2007) · Chemical Communications · doi:10.1039/b615134e · Cited by 1,278
Thiol chemistry and specificity in redox signaling
Winterbourn, C. C., & Hampton, M. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.004 · Cited by 1,226
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173
Oxidative stress and Alzheimer disease
Christen, Y. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,158
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Dewhirst, M. W., Cao, Y., & Moeller, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2397 · Cited by 1,022
Research works printed but not linked: 47
- 10.1007/s11095-005-9225-1 · doi:10.1007/s11095-005-9225-1
- 10.1007/s00701-003-0052-z · doi:10.1007/s00701-003-0052-z
- 10.1016/j.freeradbiomed.2009.06.016 · doi:10.1016/j.freeradbiomed.2009.06.016
- 10.1039/b618482k · doi:10.1039/b618482k
- Batinić-Haberle I, , Spasojević I, , Stevens RD, , Hambright P, , Neta P, , Okado-Matsumoto A, , Fridovich I. New class of potent catalysts of O2·− dismutation. Mn(III) methoxyethylpyridyl- and methoxyethylimidazolylporphyrins. J Chem Soc Dalton Trans, 1696–1702. 2004.
- 10.1002/1521-3773(20001117)39:22<4048::AID-ANIE4048>3.0.CO;2-7 · doi:10.1002/1521-3773(20001117)39:22<4048::aid-anie4048>3.0.co;2-7
- 10.1016/0022-1902(74)80108-9 · doi:10.1016/0022-1902(74)80108-9
- 10.1016/j.freeradbiomed.2008.04.006 · doi:10.1016/j.freeradbiomed.2008.04.006
- 10.1039/DT9820000931 · doi:10.1039/dt9820000931
- Cernanec JM, , Weinberg BJ, , Batinić-Haberle I, , Guilak F, , Fermor B. Influence of oxygen tension on interleukin-1-induced peroxynitrite formation and matrix turnover in articular cartilage. J Rheumatol, 34:401–407. 2007.
- 10.1021/cb900166q · doi:10.1021/cb900166q
- 10.1021/bk-2005-0903.ch017 · doi:10.1021/bk-2005-0903.ch017
- Daroczi B, , Kari G, , Zengin AY, , Chinnaiyan P, , Batinić-Haberle I, , Rodeck U, , Dicker AP. Radioprotective effects of two superoxide dismutase (SOD) mimetics and the nanoparticle DF-1 in a vertebrate zebrafish model (abstract) 48th ASTRO, Annual Meeting of the American Society for Radiation Oncology, 2006.
- Doctrow SR, , Baudry M, , Huffman K, , Malfroy B, , Melov S. Salen-manganese complexes: multifunctional catalytic antioxidants protective in models for neurodegenerative diseases of aging in Medicinal Inorganic Chemistry. American Chemical Society Symposium Series 903. Sessler JS, , Doctrow SR, , McMurray TJ, , Lippard SJ. ACS and Oxford University Press, 2005; 319–347.
- 10.1021/jp0655975 · doi:10.1021/jp0655975
- 10.1021/jp804743g · doi:10.1021/jp804743g
- 10.1021/tx0342363 · doi:10.1021/tx0342363
- Gridley DS, , Makinde AY, , Luo X, , Rizvi A, , Crapo JD, , Dewhirst MW, , Moeller BJ, , Pearlstein RD, , Slater JM. Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model. Anticancer Res, 27:3101–3109. 2007.
- 10.1002/(SICI)1521-3773(19990517)38:10<1427::AID-ANIE1427>3.0.CO;2-1 · doi:10.1002/(sici)1521-3773(19990517)38:10<1427::aid-anie1427>3.0.co;2-1
- 10.1016/S0360-3016(98)00317-4 · doi:10.1016/s0360-3016(98)00317-4
- 10.1016/0020-1650(81)80035-9 · doi:10.1016/0020-1650(81)80035-9
- Jackson IL, , Gaunter-Fleckenstein BM, , Batinić-Haberle I, , Poulton S, , Zhao Y, , Dewhirst MW, , Vujasković Z. Hyperthermia enhances the anti-angiogenic effect of metalloporphyrin mimetic of superoxide dismutase. 24th Annual Meeting of the European Society for Hyperthermic Oncology: Prague, Czech Republic, 2007.
- 10.1016/S0891-5849(98)90040-5 · doi:10.1016/s0891-5849(98)90040-5
- 10.1016/S0041-008X(02)00044-3 · doi:10.1016/s0041-008x(02)00044-3
- 10.1080/152873901316981295 · doi:10.1080/152873901316981295
- Kos I, , Rebouças JS, , Sheng H, , Warner DS, , Spasojević I, , Batinić-Haberle I. Oral availability of MnTE-2-PyP5+, a potent antioxidant and cellular redox modulator. Free Radic Biol Med, 45:S86. 2008.
- 10.1016/j.bbrc.2005.06.102 · doi:10.1016/j.bbrc.2005.06.102
- 10.1016/S1381-1169(02)00137-1 · doi:10.1016/s1381-1169(02)00137-1
- Makinde AY, , Luo-Owen X, , Rizvi A, , Crapo JD, , Pearlstein RD, , Slater JM, , Gridley DS. Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation. Anticancer Res, 29:107–118. 2009.
- 10.1021/ja00498a038 · doi:10.1021/ja00498a038
- 10.1021/bi00279a016 · doi:10.1021/bi00279a016
- 10.1021/bi00292a024 · doi:10.1021/bi00292a024
- 10.1016/S0891-5849(02)00865-1 · doi:10.1016/s0891-5849(02)00865-1
- 10.1142/S1088424602000087 · doi:10.1142/s1088424602000087
- 10.1016/j.jpba.2009.07.002 · doi:10.1016/j.jpba.2009.07.002
- 10.1016/j.tetlet.2008.04.113 · doi:10.1016/j.tetlet.2008.04.113
- 10.1016/j.ejphar.2006.12.039 · doi:10.1016/j.ejphar.2006.12.039
- 10.1021/ic8007415 · doi:10.1021/ic8007415
- 10.1021/j100207a021 · doi:10.1021/j100207a021
- 10.1016/j.jinorgbio.2006.07.013 · doi:10.1016/j.jinorgbio.2006.07.013
- Spasojevic I Sheng H Warner DS Batinic-Haberle I. Metalloporphyrins are versatile and powerful therapeutics: biomimetics of SOD peroxyredoxin and cyt P450. 2nd World Conference on Magic Bullets (Ehrlich II): Nurnberg 2008.
- 10.1016/j.transproceed.2007.08.091 · doi:10.1016/j.transproceed.2007.08.091
- 10.1021/j100207a020 · doi:10.1021/j100207a020
- 10.1002/chem.200601148 · doi:10.1002/chem.200601148
- 10.1080/10715760600801298 · doi:10.1080/10715760600801298
- Ye X, , Fels D, , Dedeugd C, , Dewhirst MW, , Leong K, , Batinic-Haberle I. The in vitro cytotoxic effects of Mn(III) alkylpyridylporphyrin/ascorbate system on four tumor cell lines. Free Radic Biol Med, 47:S136. 2009.
- Yu L, , Ji X, , Derrick M, , Drobyshevsky A, , Liu T, , Batinic-Haberle I, , Tan S. Testing new porphyrins in in vivo model system: effect of Mn porphyrins in animal model of cerebral palsy (abstract) Sixth International Conference on Porphyrins and Phthalocyanines, New Mexico, 2010.
Cited by
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
Wei, H., & Wang, E. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35486e · Cited by 3,779
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Free radicals and antioxidants – quo vadis?
Halliwell, B. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.12.002 · Cited by 706
Singh, N., Savanur, M. A., Srivastava, S., D'Silva, P., & Mugesh, G. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201708573 · Cited by 657
Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Jungwirth, U., Kowol, C. R., Keppler, B. K., Hartinger, C. G., Berger, W., & Heffeter, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3663 · Cited by 554
Metadata
- Authors
- Batinić-Haberle, I., Rebouças, J. S., & Spasojević, I.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2010-09
- Volume
- 13
- Issue
- 6
- Pages
- 877-918
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1987096917
- Cited by
- 531
- References
- 313
- FWCI
- 27.37
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential. https://app.cochat.ai/papers/10.1089/ars.2009.2876
- The paper
- Batinić-Haberle, I., Rebouças, J. S., & Spasojević, I. (2010). Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2009.2876
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.